Table 3. Initial treatment.
| 1st line therapy | GCB (n=111) | non-GCB (n=209) | Total (n=320) | P-value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |||||
| R-CHOP-like*1 | 96 | 86.5 | 195 | 93.3 | 291 | 90.9 | ||||
| Other regimens*2 | 6 | 5.4 | 5 | 2.4 | 11 | 3.4 | - | |||
| Operation | 1 | 0.9 | 1 | 0.5 | 2 | 0.6 | - | |||
| Radiation | 0 | 0 | 1 | 0.5 | 1 | 0.3 | - | |||
| Not available*3 | 5 | 4.5 | 6 | 2.9 | 11 | 3.4 | - | |||
| Unknown | 3 | 2.7 | 1 | 0.5 | 4 | 1.3 | - | |||
| Achieve CR1 | 86 | 77.5 | 110 | 52.6 | 196 | 61.3 | 1.28E-05 | |||
1* R-CHOP, R-THP-COP, Rw-CHOP, R-COP, R-CHP, R-CHO.
2* CHOP, R, DA-EPOCH-R, HDMA, Obinutuzumab-CHOP.
3* PSL.